Some novel apoA-I mimetic peptide, such as D-4F (93) and P12 (94), were believed to suppress atherosclerosis by promoting physiological HDL function in vitro studies or a murine model of diabetic atherosclerosis. Here, APOA1 is linked to atherosclerosis.